Topic Review
Complication
A complication in medicine, or medical complication, is an unfavorable result of a disease, health condition, or treatment. Complications may adversely affect the prognosis, or outcome, of a disease. Complications generally involve a worsening in severity of disease or the development of new signs, symptoms, or pathological changes which may become widespread throughout the body and affect other organ systems. Thus, complications may lead to the development of new diseases resulting from a previously existing disease. Complications may also arise as a result of various treatments. The development of complications depends on a number of factors, including the degree of vulnerability, susceptibility, age, health status, and immune system condition. Knowledge of the most common and severe complications of a disease, procedure, or treatment allow for prevention and preparation for treatment if they should occur. Complications are not to be confused with sequelae, which are residual effects that occur after the acute (initial, most severe) phase of an illness or injury. Sequelae can appear early in the development of disease or weeks to months later and are a result of the initial injury or illness. For example, a scar resulting from a burn or dysphagia resulting from a stroke would be considered sequelae. In addition, complications should not be confused with comorbidities, which are diseases that occur concurrently but have no causative association.
  • 608
  • 17 Oct 2022
Topic Review
Zebrafish Model to Understand Epigenetics
Epigenetic modifications are able to alter gene expression and include DNA methylation, different histone variants, and post-transcriptional modifications (PTMs), such as acetylation or phosphorylation, and through short/long RNAs, respectively. In this review, we focus on current knowledge concerning epigenetic modifications in gene regulation. We describe different forms of epigenetic modifications and explain how epigenetic changes can be detected. The relevance of epigenetics in renal diseases is highlighted with multiple examples and the use of the zebrafish model to study glomerular diseases in general and epigenetics in renal diseases in particular is discussed. We end with an outlook on how to use epigenetic modifications as a therapeutic target for different diseases. Here, the zebrafish model can be employed as a high-throughput screening tool not only to discover epigenetic alterations contributing to disease, but also to test novel substances that change epigenetic signatures in vivo. Therefore, the zebrafish model harbors the opportunity to find novel pathogenic pathways allowing a pre-selection of potential targets and compounds to be tested for renal diseases. 
  • 607
  • 29 Nov 2021
Topic Review
Thymus Gland
The thymus gland is the chief lymphoid organ that regulates the functions of the immune and endocrine systems by controlling the levels of hormones and cytokines. The thymus gland protects against various internal and external stresses through immunoregulatory properties, nerve systems, and endocrine pathways. The thymus gland controls cell proliferation, apoptosis, hormones, and neuropeptides, as well as regulating intrathymic T cell differentiation and production of a repertoire of the T cell.
  • 600
  • 26 Oct 2021
Topic Review
PIPAC
Theoretical considerations as well as comprehensive preclinical and clinical data suggest that optimizing physical parameters of intraperitoneal drug delivery might help to circumvent initial or acquired resistance of peritoneal metastasis (PM) to chemotherapy. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel minimally invasive drug delivery system systematically addressing the current limitations of intraperitoneal chemotherapy. The rationale behind PIPAC is: (1) optimizing homogeneity of drug distribution by applying an aerosol rather than a liquid solution; (2) applying increased intraperitoneal hydrostatic pressure to counteract elevated intratumoral interstitial fluid pressure; (3) limiting blood outflow during drug application; (4) steering environmental parameters (temperature, pH, electrostatic charge etc.) in the peritoneal cavity for best tissue target effect. In addition, PIPAC allows repeated application and objective assessment of tumor response by comparing biopsies between chemotherapy cycles. 
  • 599
  • 09 Aug 2021
Topic Review
Role of Cytokine IL-37 in Modulating Inflammation
Inflammation constitutes an essential response of tissues to infection or injury. The cytokine IL-37 is a member of the IL-1 family of cytokines, otherwise known for its pivotal role in promoting inflammation. This cytokine (a former member 7 of the IL-1 family) was characterized by computational cloning, which revealed its role as a negative regulator of the cytokine IL-18, which in addition to IL-1β is the key proinflammatory cytokine of the IL-1 cytokine family. There is growing interest in the therapeutic potentials of IL-37.
  • 596
  • 20 Jun 2022
Topic Review
Sarcopenia and Cognitive Function
Sarcopenia is a geriatric syndrome characterized by the progressive degeneration of muscle mass and function. It is associated with cognitive impairment, defined as a decline in cognitive domains such as language, memory, reasoning, social cognition, planning, making decisions, and solving problems. Several studies have shown that skeletal muscle can regulate brain functions, including mood, learning, locomotor activity, and neuronal injury protection, showing the existence of muscle-brain crosstalk. 
  • 595
  • 04 Jun 2021
Topic Review
Exosome-Derived MicroRNAs of Human Milk
Multiple biologically active components of human milk support infant growth, health and development. Milk provides a wide spectrum of mammary epithelial cell-derived extracellular vesicles (MEVs) for the infant. Although the whole spectrum of MEVs appears to be of functional importance for the growing infant, the majority of recent studies report on the MEV subfraction of milk exosomes (MEX) and their miRNA cargo, which are in the focus of this entry.
  • 590
  • 23 Jun 2021
Topic Review
Saliva biomarkers for Heart Failure
Heart Failure (HF) is a clinical syndrome characterized by symptoms such as dyspnoea or fatigue on exertion or at rest, and clinical signs (i.e. lower extremity oedema, elevated jugular venous pressure, pulmonary crackles, etc.) caused by a structural and/or functional cardiac abnormality, ultimately leading to reduced cardiac output. Despite advances in the knowledge on HF, decisions on diagnosis and treatment of HF remain challenging. In everyday clinical practice, biomarkers such as plasma natriuretic peptides such as brain natriuretic peptide (BNP) and N-terminal fragment BNP (NT-proBNP), play an important role in HF diagnosis, therapy monitoring and risk stratification, while many other serum biomarkers have also been studied without definite evidence on how to use them in clinical practice. Biomarkers that could be measured in other biological fluids other than blood, easily and non-invasively, and outside the hospital setting, have attracted research interest. During the last years, saliva has emerged as a body fluid for this purpose.  This review assessed the potential role of salivary biomarkers in diagnosis and progression monitoring of patients with HF. 18 salivary biomarkers were analyzed and the levels of all biomarkers studied were found to be higher in HF patients compared to controls, except for amylase, sodium, and chloride that had smaller saliva concentrations in HF patients. Natriuretic peptides are the most commonly used plasma biomarkers in the management of HF. Their saliva levels show promising results, although the correlation of saliva to plasma values is weakened in higher plasma values. In most of the publications, differences in biomarker levels between HF patients and controls were found to be statistically significant. Due to small number of patients included, larger studies need to be conducted in order to facilitate the use of saliva biomarkers in clinical practice.
  • 588
  • 19 May 2021
Topic Review
JDP2 in Cardiac Disease
Heart failure (HF) and atrial fibrillation (AF) are two major life-threatening diseases worldwide. Causes and mechanisms are incompletely understood, yet current therapies are unable to stop disease progression. In our study, we focus on the contribution of the transcriptional modulator, Jun dimerization protein 2 (JDP2), and on HF and AF development. In recent years, JDP2 has been identified as a potential prognostic marker for HF development after myocardial infarction. This close correlation to the disease development suggests that JDP2 may be involved in initiation and progression of HF as well as in cardiac dysfunction.
  • 586
  • 28 Apr 2021
Topic Review
Kynurenine Pathway of Tryptophan Metabolism
Migraine, the leading cause of disability in the population aged below 50, is frequently associated with functional gastrointestinal (GI) disorders (FGIDs) such as functional nausea, cyclic vomiting syndrome, and irritable bowel syndrome (IBS). Conversely, changes in intestinal GI transit may cause diarrhea or constipation and are a component of the autonomic symptoms associated with pre- and post-dorsal phases of migraine attack. 
  • 586
  • 28 Sep 2021
  • Page
  • of
  • 48
Video Production Service